"
Team:BIOSINT Mexico/finacial
From 2012e.igem.org
| (4 intermediate revisions not shown) | |||
| Line 128: | Line 128: | ||
<div class="p-border"> | <div class="p-border"> | ||
<div class="wrap"> | <div class="wrap"> | ||
| - | <p class="clr-1">Initial investment.</p> | + | <p class="clr-1"><strong>Initial investment.</strong></p> |
</div> | </div> | ||
| - | <p> | + | <p>Pre-operative expenses: The business incubator of the ITESM Campus Querétaro and the Parque Tecnológico have helped in the creation of Kuxtal Biotech, these institutions provided personal assessment as part of a pre-incubation process that have a total cost of 446.71 USD. </br></br> |
| + | Financial Plan: The required initial investment is $725,732.14 USD, to obtain this value, the following was considered:</br> | ||
| + | • $644,095.14 USD related to fixed assets, this includes all the laboratory equipment, and office equipment.</br> | ||
| + | • $6,561.54 USD related to deferred assets, this includes publicity, rent, installations, and preoperative expenses.</br> | ||
| + | • $75,075.46 USD related to circulating assets, this includes the necessary capital to be able to work for six months.</br></br> | ||
| + | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
| Line 137: | Line 142: | ||
<div class="p-border"> | <div class="p-border"> | ||
<div class="wrap"> | <div class="wrap"> | ||
| - | <p class="clr-1">Financial indicators.</p> | + | <p class="clr-1"><strong>Financial indicators.</strong></p> |
</div> | </div> | ||
| - | <p> | + | <p>• The operation budget will be $63,114.69 USD, this includes salary wages for personal in charge of production and indirect expenses of production.</br> |
| + | • The administration budget will be $67,230.77 USD, this includes salary wages for administrative staff and the expenses related to this department.</br> | ||
| + | • The travel expenses budget for the salesmen staff will be $6,153.85USD.</br></br> | ||
| + | The equilibrium point was calculated as follows: </br> | ||
| + | (Total fixed costs)/(Sale price-Variable costs)</br> | ||
| + | Considering this, Kuxtal Biotech needs to sale 38,758.49 oligonucleotides with 20 bp of length to finance the expenses but without any earnings. | ||
| + | |||
| + | </br></br> | ||
| + | |||
| + | |||
| + | <div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/Balancep.png"/></div> | ||
| + | </p> | ||
</div> | </div> | ||
| Line 147: | Line 163: | ||
<div class="p-border"> | <div class="p-border"> | ||
<div class="wrap"> | <div class="wrap"> | ||
| - | <p class="clr-1">Project evaluation.</p> | + | <p class="clr-1"><strong>Project evaluation.</strong></p> |
</div> | </div> | ||
| - | <p> | + | <p><div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/Finanzas.png"/></div></p> |
</div> | </div> | ||
Latest revision as of 02:17, 28 October 2012
Initial investment.
Pre-operative expenses: The business incubator of the ITESM Campus Querétaro and the Parque Tecnológico have helped in the creation of Kuxtal Biotech, these institutions provided personal assessment as part of a pre-incubation process that have a total cost of 446.71 USD. Financial Plan: The required initial investment is $725,732.14 USD, to obtain this value, the following was considered: • $644,095.14 USD related to fixed assets, this includes all the laboratory equipment, and office equipment. • $6,561.54 USD related to deferred assets, this includes publicity, rent, installations, and preoperative expenses. • $75,075.46 USD related to circulating assets, this includes the necessary capital to be able to work for six months.
Financial indicators.
• The operation budget will be $63,114.69 USD, this includes salary wages for personal in charge of production and indirect expenses of production. • The administration budget will be $67,230.77 USD, this includes salary wages for administrative staff and the expenses related to this department. • The travel expenses budget for the salesmen staff will be $6,153.85USD. The equilibrium point was calculated as follows: (Total fixed costs)/(Sale price-Variable costs) Considering this, Kuxtal Biotech needs to sale 38,758.49 oligonucleotides with 20 bp of length to finance the expenses but without any earnings.
Project evaluation.
